ARTICLE
14 May 2020

Governor Lamont Suspends Regulations To Expand COVID-19 Testing

SG
Shipman & Goodwin LLP

Contributor

Shipman & Goodwin LLP  logo
Shipman & Goodwin’s value lies in our commitment -- to our clients, to the profession and to the community. We have one goal: to help our clients achieve their goals. How we accomplish it is simple: we devote our considerable experience and depth of knowledge to understand each client’s unique needs, business and industry, and then we develop solutions to meet those needs. Clients turn to us when they need a trusted advisor. With our invaluable awareness of each client’s challenges, we can counsel them at every step -- to keep their operations running smoothly, help them navigate complex business transactions, position them for future growth, or resolve business disputes. The success of our clients is of primary importance to us and our attorneys invest meaningful time getting to know the client's business and are skilled in the practice areas and industry sectors critical to that success. With more than 175 attorneys in offices throughout Connecticut, New York and in Washington, DC, we serve the needs of
Governor Ned Lamont recently announced that, in order to significantly increase the ability of Connecticut residents to be tested for COVID-19, his administration is suspending certain state healthcare regulations...
United States Coronavirus (COVID-19)

Governor Ned Lamont recently announced that, in order to significantly increase the ability of Connecticut residents to be tested for COVID-19, his administration is suspending certain state healthcare regulations that prescribe who may order diagnostic tests and provide such tests. Specifically, for the duration of the state public health emergency, patients are no longer required to receive a referral from a physician or other prescribing medical provider (e.g., physician assistant, advanced practice registered nurse, licensed practical nurse, or certified nurse practitioner) prior to being administered a COVID-19 test and pharmacists may now order and administer such tests.

On May 6, 2020, Department of Public Health ("DPH") Commissioner Renée D. Coleman-Mitchell issued an order modifying section 19a-36-D29(a) of the Regulations of Connecticut State Agencies such that there is no longer a requirement that "a request for collection or analysis of a COVID-19 specimen be made by a licensed physician or other licensed person authorized by law to make diagnoses." In addition, the Commissioner's order modified section 19a-36-D32(a) of the Regulations of Connecticut State Agencies such that there is no longer a requirement for laboratories to report the COVID-19 test results to a licensed provider, if the test was not ordered by such a provider. However, in the event a licensed provider does order the test, a laboratory is still required to report its findings on a COVID-19 specimen to the licensed provider.

On May 7, 2020, Governor Lamont issued Executive Order No. 7KK, which modifies section 19a-36-D29 of the Regulations of Connecticut State Agencies to permit pharmacists to order and administer Food and Drug Administration ("FDA") approved COVID-19 tests. Pharmacists are required to report all testing activities in accordance with applicable DPH orders and guidelines.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More